Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Prospective Clinical Trial for Optimizing TNF Inhibitor Dose Adjustment in Ankylosing Spondylitis Patients With Stable Disease Activity

NCT05164198 is registered in ClinicalTrials.gov with Hanyang University Seoul Hospital as lead sponsor.

NCT NCT05164198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05164198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Prospective Clinical Trial for Optimizing TNF Inhibitor Dose Adjustment in Ankylosing Spondylitis Patients With Stable Disease Activity
Lead sponsor
Hanyang University Seoul Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
January 15, 2022
Completion date
October 31, 2024
Enrollment
448 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, axial spondyloarthritis